Healthcare and Medical Device

The global interventional oncology market is projected to experience robust growth in the coming years, driven by several key factors. Valued at $1.9 billion in 2020, this market is expected to reach $2.9 billion by 2026, growing at an impressive compound annual growth rate (CAGR) of 6.8%. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164 The Rise of Minimally Invasive Cancer Treatments A major driver of market growth is the increasing patient preference for minimally invasive procedures over traditional surgical methods. These advanced techniques offer numerous advantages, including fewer complications, shorter hospital stays, reduced pain and scarring, lower infection risks, and quicker recovery times. By leveraging cutting-edge technologies, interventional oncology enables precise tumor removal and tissue sampling for accurate cancer staging and treatment planning. Addressing the Skill Gap Despite the growing demand, a shortage of we...

The global oligonucleotide synthesis market is experiencing explosive growth, projected to surge from $8.8 billion in 2024 to a staggering $19.7 billion by 2029 at a compound annual growth rate of 17.5%. This meteoric rise is fueled by several key drivers. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350 Driving Forces Behind the Market's Ascent ·          Escalating use of synthesized oligonucleotides in therapeutic and diagnostic applications, harnessing their potential to tackle a diverse array of neurological disorders, rare diseases, and gene therapy. ·          Continuous technological advancements, such as next-generation sequencing (NGS) and the revolutionary CRISPR gene-editing tool, which are catalyzing demand for oligonucleotide synthesis. ·          Burgeoning investments from governments and major industry...

The global 3D cell culture market is experiencing significant growth, projected to reach $2.5 billion by 2028, expanding at a compound annual growth rate (CAGR) of 14.6% from 2023 to 2028. This growth is fueled by several key drivers and opportunities within the industry. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847 Driving Forces: 1. Alternatives to Animal Testing: One of the primary drivers is the increasing focus on developing alternatives to animal testing in pharmaceutical and scientific research. 3D cell culture models provide a more physiologically relevant and predictive platform for studying drug efficacy and toxicity, reducing the reliance on animal models. Regulatory bodies are encouraging the adoption of these advanced in vitro models, spurring growth in the 3D cell culture industry. 2. Personalized Medicine: The rising demand for personalized medicine has led to an increased need for 3D cell culture techniques. These mod...

The global patient handling equipment market is projected to experience robust growth in the coming years, driven by several key factors. According to recent estimates, this market was valued at $10.4 billion in 2022 and is expected to reach $14.0 billion by 2027, registering a compound annual growth rate (CAGR) of 6.2% during this period. The latest report on this market provides an updated overview, including assessments across all segments from 2020 to 2027. It also offers insights into industry trends, technology analysis, pricing analysis, and patent analysis. Additionally, the report considers the impact of the ongoing economic recession on market sizing and provides qualitative insights on its regional impact. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186358368 Fueling the growth of this market is a combination of factors, such as the growing number of geriatric and obese populations, the high risk of injuries to caregivers during ma...

The global enteral feeding devices market is experiencing remarkable growth, fueled by the increasing prevalence of chronic diseases and the aging population. Valued at $4.0 billion in 2023, this market is projected to reach $5.6 billion by 2029, growing at a robust compound annual growth rate (CAGR) of 6.2%. Enteral feeding devices play a crucial role in delivering essential nutrients directly into the digestive system, offering a lifeline to patients who cannot consume food orally due to various medical conditions. As the world's population ages and the incidence of chronic illnesses rises, the demand for these devices is soaring. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035 Driving Forces Behind the Growth The rapid growth of the geriatric population and the accompanying rise in age-related chronic diseases are the primary drivers of this market's expansion. With advances in healthcare and improved living standards, people...

The global protein expression market is expected to experience substantial growth in the coming years, projected to expand from $2.9 billion in 2022 to $5.4 billion by 2027 at a compound annual growth rate (CAGR) of 13.3%. This burgeoning market is driven by several key factors, including the increasing demand for protein biologics, particularly in the treatment of chronic diseases such as cancer, autoimmune disorders, and other serious conditions. As the life science and biopharmaceutical industries continue to thrive, the focus on recombinant protein expression and the availability of investments for protein-based research are providing further impetus to the market's growth. However, the high cost of protein expression reagents and instruments remains a restraining factor, potentially limiting adoption in certain areas. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924 One of the notable trends shaping the market is the emergence of ...

The market for Autoimmune Disease Diagnosis is experiencing rapid growth and is projected to expand from $4.1 billion in 2020 to $6.3 billion by 2025, increasing at an impressive 8.9% annual rate. Several key factors are fueling this market's expansion. Rising Autoimmune Disease Rates Drive Demand Perhaps the biggest driver is the high and increasing prevalence of autoimmune conditions like rheumatoid arthritis, lupus, Sjögren's syndrome and thyroiditis. As these diseases become more common, the need for accurate diagnostic tests grows correspondingly. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519 Greater Awareness Spurring Testing Along with higher disease rates, increased public and medical awareness about autoimmune disorders is prompting more patients to seek testing and diagnosis. Extensive research into understanding and treating these conditions is also contributing to market growth. Consumables Lead Product Segment...